Gilead Sciences
GILD
#174
Rank
$90.68 B
Marketcap
$72.78
Share price
-0.57%
Change (1 day)
-12.84%
Change (1 year)

P/E ratio for Gilead Sciences (GILD)

P/E ratio as of February 2024 (TTM): 16.6

According to Gilead Sciences's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 16.5786. At the end of 2022 the company had a P/E ratio of 23.4.

P/E ratio history for Gilead Sciences from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202223.459.47%
202114.7-97.48%
20205833701.51%
201915.32.96%
201814.9-26.45%
201720.2184.87%
20167.10-13.23%
20158.19-30.86%
201411.8-68.31%
201337.473.46%
201221.591.56%
201111.24.87%
201010.7-27.65%
200914.8-37.99%
200823.9-9.63%
200726.4-206.29%
2006-24.9-184.23%
200529.5-12.22%
200433.6-122.51%
2003-149-262.62%
200291.9-20.3%
2001115

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
11.4-31.29%๐Ÿ‡บ๐Ÿ‡ธ USA
14.8-10.66%๐Ÿ‡บ๐Ÿ‡ธ USA
48.0 189.66%๐Ÿ‡บ๐Ÿ‡ธ USA
142 755.06%๐Ÿ‡บ๐Ÿ‡ธ USA
20.2 21.57%๐Ÿ‡บ๐Ÿ‡ธ USA
12.1-27.30%๐Ÿ‡บ๐Ÿ‡ธ USA
-5.09-130.73%๐Ÿ‡บ๐Ÿ‡ธ USA
32.6 96.66%๐Ÿ‡บ๐Ÿ‡ธ USA
71.0 328.00%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.